AI Science Tracker

Machine-learning selection and external mass-spectrometry testing identify an ARDS 28-day prognosis protein panel

Fudan University; Zhongshan Hospital, Fudan University; Shanghai Jiao Tong University School of Medicine; collaborating Shanghai hospitals · 2 Jul 2024 · medicine

Discovery

Machine-learning selection and external mass-spectrometry testing identify an ARDS 28-day prognosis protein panel

A multicenter observational serum multi-omics study used LASSO and Boruta to select candidate biomarkers for 28-day outcome in acute respiratory distress syndrome. Eight proteins (VCAM1, LDHB, MSN, FLG2, TAGLN2, LMNA, MBL2 and LBP) showed consistency in an independent cohort of 183 patients and were confirmed by targeted parallel-reaction-monitoring mass spectrometry. The protein model AUC was 0.802 in validation versus 0.738 for the clinical model. The discovery analysis also reported sphingosine-1-phosphate association with ARDS prognosis and an enriched sphingolipid pathway.

Technology: LASSO and Boruta feature selection; machine-learning prognostic model; targeted PRM validation

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Eight proteins (VCAM1, LDHB, MSN, FLG2, TAGLN2, LMNA, MBL2 and LBP) showed consistency in an independent cohort of 183 patients and were confirmed by targeted parallel-reaction-monitoring mass spectrometry.
  • Still unknown: Observational prognostic associations do not show proteins cause outcomes or that biomarker-guided care improves survival. Discovery n=130 ARDS patients; validation n=183. PRM confirmation is not independent replication by another group; deployment and prospective benefit were not established.
  • AI role: LASSO, fold-change screening and Boruta prioritized candidate 28-day ARDS prognostic proteins; candidates were tested by targeted PRM in an external cohort.

Evidence sources: https://pubmed.ncbi.nlm.nih.gov/38956604/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 41 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.